MoneyWorks4Me

The revenue zoomed 7.04% to Rs. 13430.80 millions for the quarter ended March 2023 as compared to Rs. 12547.50 millions during the corresponding quarter last year.A humble growth in net profit of 9.47% reported in the quarter ended March 2023 to Rs. 2314.20  millions from Rs. 2114.10 millions.Operating profit surged to 3297.60 millions from the corresponding previous quarter of 3148.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 13430.80 12547.50 7.04 53487.30 49133.20 8.86 53487.30 49133.20 8.86
Other Income 496.40 213.20 132.83 1541.50 831.60 85.37 1541.50 831.60 85.37
PBIDT 3297.60 3148.70 4.73 13597.80 11649.30 16.73 13597.80 11649.30 16.73
Interest 40.10 51.40 -21.98 159.90 191.00 -16.28 159.90 191.00 -16.28
PBDT 3257.50 3097.30 5.17 13437.90 11458.30 17.28 13437.90 11458.30 17.28
Depreciation 173.40 174.30 -0.52 699.70 661.00 5.85 699.70 661.00 5.85
PBT 3084.10 2923.00 5.51 12738.20 10797.30 17.98 12738.20 10797.30 17.98
TAX 769.90 808.90 -4.82 3244.10 2810.30 15.44 3244.10 2810.30 15.44
Deferred Tax 35.40 74.20 -52.29 -11.90 -1.30 815.38 -11.90 -1.30 815.38
PAT 2314.20 2114.10 9.47 9494.10 7987.00 18.87 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 24.55 25.09 -2.16 25.42 23.71 7.22 25.42 23.71 7.22
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..